CAMP4 Therapeutics CorporationCAMPNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P21
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-1.58%
2024-4.43%
202316.81%
202222.24%
202110.20%
2020-12.31%
20196.44%
20187.36%
201717.07%
201611.12%